Senior insider sale
Chief Medical Officer at STARLING ONCOLOGY, INC. — senior position signals high conviction
$280.7K
48.71K shares
What this filing means
PODNOS YALE plans to sell 48.71K shares of STARLING ONCOLOGY, INC. valued at approximately $280.7K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 7/14/2026ACC: 0001950047-26-007065
Officer· Chief Medical Officer
Since Nov 2021
48.71K
Shares to sell
$280.7K
Approx. market value
23.45K
Acquired (3 months)
1
Planned
2 completed
Securities Acquired — Last 3 Months1
Exercise of Stock Options
Cash
7/14/2026
23.45KTotal acquired23.45K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
7/14/2026 | Exercise of Stock Options Cash | 23.45K | — |
| Total | 23.45K | ||
Planned & Completed Dispositions3
Completed
—Completed
Units to sell
23.45K
Market value
$126.1K
6/8/2026
—Completed
Units to sell
1.80K
Market value
$8.1K
5/21/2026
Planned — Approximate Date
NASDAQPlanned
Units to sell
23.45K
Market value
$146.6K
7/14/2026
Total
Units
48.71K
Value
$280.7K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
6/8/2026 | 23.45K | $126.1K | — | Completed |
5/21/2026 | 1.80K | $8.1K | — | Completed |
| Planned — Approximate Date | ||||
7/14/2026 | 23.45K | $146.6K | NASDAQ | Planned |
| Total | 48.71K | $280.7K | ||